Cost of fractures commonly associated with osteoporosis in a managed-care population

Journal of Medical Economics

Volumn 13, Issue 2, 2010, Pages 302-313

  Christensen, L ^a   Iqbal, S ^b   Macarios, D ^b   Badamgarav, E ^b   Harley, C ^a,c  

^a I3 Innovus   (United States)

^b AMGEN INC   (United States)

^c I3 Innovus   (United States)

Author keywords

Bone; Closed; Fractures; Healthcare costs; Osteoporosis

Indexed keywords

ALENDRONIC ACID; IBANDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID;

ADULT; AGED; ARTICLE; BILLING AND CLAIMS; BONE FRAGILITY; COHORT ANALYSIS; CONTROLLED STUDY; COST OF ILLNESS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG COST; FEMALE; FOLLOW UP; FRACTURE; HEALTH CARE COST; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICARE; OSTEOPOROSIS; PHARMACY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VERTEBRA FRACTURE;

AGE FACTORS; AGED; BONE DENSITY CONSERVATION AGENTS; FEMALE; FRACTURES, BONE; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; INSURANCE CLAIM REVIEW; MALE; MANAGED CARE PROGRAMS; MEDICARE PART C; MIDDLE AGED; OSTEOPOROSIS; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SEX FACTORS; UNITED STATES;

EID: 77953342300     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696998.2010.488969     Document Type: Article

References (24)

1. US Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Washington, DC: Office of the Surgeon General, October 14, 2004.
2. World Health Organization. WHO scientific group on the assessment of osteoporosis at primary health care level. Summary Meeting Report (Brussels, Belgium, May 5-7, 2004), 2007.
3. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22:465-475.
4. US Department of Labor, Bureau of Labor Statistics. Consumer Price Index. Chained Consumer Price Index for all urban consumers (C-CPI-U) 1999-2008, Medical Care. Series ID: SUUR0000SAM. Washington, DC: U.S. Dept. of Labor, Bureau of Labor Statistics, 2008. http://data.bls.gov/cgi-bin/surveymost?su
5. Ohsfeldt RL, Borisov NN, Sheer RL. Fragility fracture-related direct medical costs in the first year following a nonvertebral fracture in a managed care setting. Osteoporos Int 2006;17:252-258.
6. Max W, Sinnot P, Kao C, et al. The burden of osteoporosis in California, 1998. Osteoporos Int 2002;13:493-500.
7. Henry G, Bone SL, et al. Alendronate and estrogen effects in post menopausal women with low bone mineral density. J Clin Endocrinol Metab 2000;85:720-726.
8. Hosking D, Chilvers CE, Christiansen C, et al. Prevention of bone mass with alendronate in post menopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med 1998;338:485-492.
9. Chesnut 3rd CH, McClung MR, Ensrud KE, et al. Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. Am J Med 1995;99:144-152.
10. Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 2006;38:922-928.
11. Weycker D, Macarios D, Edelsberg J, et al. Compliance with osteoporosis drug therapy and risk of fracture. Osteoporos Int 2007;18:271-277.
12. Gabriel SE, Tosteson AN, Leibson CL, et al. Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 2002;13:323-330.
13. Bass E, French DD, Bradham DD. A national perspective of Medicare expenditures for elderly veterans with hip fractures. J Am Med Dir Assoc 2008;9:114-119.
14. De Laet CE, van Hout BA, Burger H, et al. Incremental cost of medical care after hip fracture and first vertebral fracture: the Rotterdam study. Osteoporos Int 1999;10:66-72.
15. Haentjens P, Lamraski G, Boonen S. Cost and consequences of hip fracture occurrence in old age: an economic perspective. Disabil Rehabil 2005;27:1129-1141.
16. Melton 3rd LJ. Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res 2003;18:1139-1141.
17. Bouee S, Lafuma A, Fagnani F, et al. Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries. Rheumatol Int 2006;26:1063-1072.
18. Kilgore ML, Morrisey MA, Becker DJ, et al. Health care expenditures associated with skeletal fractures among Medicare beneficiaries, 1999-2005. J Bone Miner Res 2009;24:2050-2055.
19. Shi N, Foley K, Lenhart G, et al. Direct healthcare costs of hip, vertebral, and non-hip, non-vertebral fractures. Bone 2009;45: 1084-1090.
20. Roudsari BS, Ebel BE, Corso PS, et al. The acute medical care costs of fall-related injuries among the U.S. older adults. Injury 2005;36:1316-1322.
21. Nguyen TV, Center JR, Eisman JA. Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust 2004;180:S18-22.
22. Delmas PD, van de Langerijt L, Watts NB, Eastell R, Genant H, Grauer A, Cahall DL, IMPACT Study Group. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res 2005;4:557-563.
23. Gardner MJ, Flik KR, Mooar P, Lane JM. Improvement in the undertreatment of osteoporosis following hip fracture. J Bone Joint Surg Am 2002;84-A:1342-1348.
24. Orsini LS, Rousculp MD, Long SR, et al. Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures. Osteoporos Int 2005;16:359-371.